Xtant Medical Holdings, Inc.
XTNT
$0.612
-$0.008-1.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.41% | -621.48% | -2,592.27% | -738.60% | 62.25% |
| Total Depreciation and Amortization | 14.37% | 15.78% | 33.08% | 65.17% | 98.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 164.80% | 165.22% | 158.45% | 156.07% | -306.68% |
| Change in Net Operating Assets | 47.23% | 43.88% | -47.19% | 12.60% | -17.15% |
| Cash from Operations | 109.63% | 62.66% | -25.02% | -23.77% | -71.00% |
| Capital Expenditure | -125.33% | -155.56% | -182.49% | -147.66% | -5.43% |
| Sale of Property, Plant, and Equipment | -1.98% | 38.91% | 118.86% | 320.88% | 218.95% |
| Cash Acquisitions | -- | -- | -- | 90.42% | 61.75% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.31% | 47.75% | 84.95% | 76.08% | 56.63% |
| Total Debt Issued | -1.54% | 21.90% | 41.36% | 46.92% | 54.57% |
| Total Debt Repaid | -10.68% | -25.26% | -36.56% | -44.98% | -51.13% |
| Issuance of Common Stock | -68.10% | -68.10% | -68.10% | -73.68% | 50.48% |
| Repurchase of Common Stock | 20.14% | 38.85% | 31.80% | -111.76% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.71% | 60.79% | -172.38% | -- | -645.54% |
| Cash from Financing | -83.04% | -50.86% | -18.37% | -30.94% | 60.42% |
| Foreign Exchange rate Adjustments | -194.59% | -308.00% | -720.83% | 169.81% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.36% | 203.18% | 102.04% | 81.22% | 108.31% |